Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Cancer Drive Gene Mutations Detection Services In Europe
6 services found
by:Biocollect based inZator, POLAND
We offer tools and devices for cervical cancer detection and diagnostic including a self-sampling device of our partner Oasis Diagnostics® Corporation for cervico-vaginal specimen for HPV test as well as for testing other viruses and bacteria from STI ...
Manufactured by:Self-screen B.V. based inAmsterdam, NETHERLANDS
Self-screen is constantly developing novel state-of-the-art clinical tests for (early) cancer detection. These tests meet growing requirements in both primary screening as well as triage settings. This could be in terms of terms of validation of certain sample types, such as existing cytology preservatives, or other media, or for instance new sample types such as self sampling (validations for ...
Manufactured by:ITM Isotope Technologies Munich SE based inGarching / Munich, GERMANY
Targeted Radionuclide Therapy (TRT) or Peptide Receptor Radionuclide Therapy (PRRT) is a medical specialty using very small amounts of radioactive compounds, called radiopharmaceuticals, to diagnose and treat various diseases, like cancer. Once injected into the patient, the radiopharmaceutical finds its way to the tumor through the bloodstream and binds to the tumor specific receptor according ...
by:Oncimmune Holdings PLC based inNottingham, UNITED KINGDOM
EarlyCDT is a simple blood test that detects the elevated presence of autoantibodies generated by the body's immune system as a natural defence against cancer cells. EarlyCDT Lung is the world’s most thoroughly validated blood test for the detection of lung cancer and requires only a small volume of blood which can be taken in the community setting as well as a doctor’s surgery. Shown ...
Manufactured by:Soteria Medical BV based inArnhem, NETHERLANDS
Prostate cancer is the most common cancer, other than non-melanoma skin cancer, and the second leading cause of cancer-related death in men in the United States. Prostate cancer incidence rates rose dramatically in the late 1980s, when screening with the prostate-specific antigen (PSA) test, which received initial U.S. Food and Drug Administration approval in 1986, came into wide use. It is ...
by:2M Engineering Ltd. based inValkenswaard, NETHERLANDS
Driving Innovation Through our comprehensive product creation services; At 2M, we are experts in creating cutting-edge smart sensing solutions that propel innovation in various industries. Our services encompass a wide range of offerings, from providing one-time consultancy or development projects to delivering full end-to-end product creation ...